patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: Good news for those who own this stock (as I do). If, however,
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Man, PTSC really took a hit today. Makes me feel like I made a good decision to take my profits and buy into Pluristem.

I'm sure it's only a temporary setback. But I could not take constant dropping in share price on supposedly good news.

Manolo

Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply